Axoft Secures $55 Million In Series A Funding Led By C.P. Group Innovation

Axoft, a neurotechnology company based in Cambridge, Massachusetts, has raised $55 million in an oversubscribed Series A funding round led by C.P. Group Innovation, with participation from Alumni Ventures, the Stanford President’s Venture Fund, Hillhouse Investment, and Gaorong Ventures. This funding brings the company's total financing to over $60 million and will be used to support global clinical trials, the establishment of a GMP manufacturing facility in Boston, and efforts toward U.S. regulatory approval.

Summary of transaction details:

• Deal Type: Series A
• Transaction Amount: $55,000,000
• Company: Axoft
• Founders: Paul Le Floch, Tianyang Ye, Jia Liu
• Headquarters Location: Cambridge, Massachusetts
• Notable Investors: C.P. Group Innovation, Alumni Ventures, Stanford President’s Venture Fund, Hillhouse Investment, Gaorong Ventures

Co-founded by Paul Le Floch, Tianyang Ye, and Jia Liu, Axoft has successfully implanted its brain-computer interface in over 11 patients. The company is also advancing its proprietary Fleuron material, which is designed to be significantly softer than traditional implant materials, aiming to reduce tissue damage and improve signal quality.